Psychopharmacology and Psychiatry Updates cover image

Pharmacogenetics: Separating Science from Marketing

Psychopharmacology and Psychiatry Updates

00:00

QTC risks and FDA testing requirements

Chris Aiken outlines cardiac risk from high drug levels and FDA testing requirements for pimazide, thioridazine, citalopram, deutetrabenazine, and valbenazine.

Play episode from 02:51
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app